Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study (Q33403930)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study |
scientific article |
Statements
1 reference
Effect of the MDM2 antagonist RG7112 on the P53 pathway in patients with MDM2-amplified, well-differentiated or dedifferentiated liposarcoma: an exploratory proof-of-mechanism study (English)
1 reference
Antoine Italiano
1 reference
Jianguo Zhi
1 reference
Florian Heil
1 reference
Ruediger Rueger
1 reference
Bradford Graves
1 reference
Meichun Ding
1 reference
David Geho
1 reference
Steven A Middleton
1 reference
Lyubomir T Vassilev
1 reference
Gwen L Nichols
1 reference
Binh Nguyen Bui
1 reference
17 October 2012
1 reference
1 reference
Identifiers
1 reference